DK1490037T3 - Smagsmaskeret faste sammensætninger af veterinærmedicin - Google Patents

Smagsmaskeret faste sammensætninger af veterinærmedicin

Info

Publication number
DK1490037T3
DK1490037T3 DK03711962T DK03711962T DK1490037T3 DK 1490037 T3 DK1490037 T3 DK 1490037T3 DK 03711962 T DK03711962 T DK 03711962T DK 03711962 T DK03711962 T DK 03711962T DK 1490037 T3 DK1490037 T3 DK 1490037T3
Authority
DK
Denmark
Prior art keywords
taste
solid compositions
veterinary medicine
masked solid
masked
Prior art date
Application number
DK03711962T
Other languages
Danish (da)
English (en)
Inventor
Hubert Thoma
Uwe Thomas Schote
Ute Isele
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27798784&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1490037(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK1490037T3 publication Critical patent/DK1490037T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
DK03711962T 2002-03-11 2003-03-10 Smagsmaskeret faste sammensætninger af veterinærmedicin DK1490037T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02005511 2002-03-11
PCT/EP2003/002446 WO2003075895A1 (fr) 2002-03-11 2003-03-10 Compositions solides veterinaires a gout masque

Publications (1)

Publication Number Publication Date
DK1490037T3 true DK1490037T3 (da) 2008-07-21

Family

ID=27798784

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03711962T DK1490037T3 (da) 2002-03-11 2003-03-10 Smagsmaskeret faste sammensætninger af veterinærmedicin

Country Status (22)

Country Link
US (2) US20050169971A1 (fr)
EP (2) EP1490037B1 (fr)
JP (1) JP4663985B2 (fr)
KR (1) KR20040101302A (fr)
CN (1) CN1652754B (fr)
AR (1) AR038899A1 (fr)
AT (1) ATE390129T1 (fr)
AU (1) AU2003218722B2 (fr)
BR (1) BR0308378B1 (fr)
CA (1) CA2478811C (fr)
CO (1) CO5400144A1 (fr)
DE (1) DE60319969T2 (fr)
DK (1) DK1490037T3 (fr)
ES (1) ES2301784T3 (fr)
MX (1) MXPA04008845A (fr)
NZ (1) NZ535167A (fr)
PT (1) PT1490037E (fr)
RU (1) RU2318498C2 (fr)
SI (1) SI1490037T1 (fr)
TW (1) TWI309557B (fr)
WO (1) WO2003075895A1 (fr)
ZA (1) ZA200407010B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007519746A (ja) * 2004-01-29 2007-07-19 バイオシネクサス インコーポレーティッド ワクチン調製におけるアミノ−オキシ官能基の使用
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (fr) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Utilisation des inhibiteurs de PDE III pour la réduction de la taille du coeur chez des mammifères souffrant d'insufficances cardiaques
WO2005123042A1 (fr) * 2004-06-10 2005-12-29 Glatt Air Techniques, Inc. Preparation pharmaceutique a liberation lente
EP1753398B1 (fr) * 2004-06-10 2018-09-19 Glatt Air Techniques, Inc. Formulation a dosage pharmaceutique contenant une matrice a liberation controlee
EP1920785A1 (fr) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Préparation liquide contenant un complexe du pimobendane et de la cyclodextrine
EP1935405A1 (fr) * 2006-12-22 2008-06-25 LEK Pharmaceuticals D.D. Comprimés à désintégration orale
BR112014003117A2 (pt) 2011-08-12 2017-06-13 Boehringer Ingelheim Vetmedica Gmbh inibidores da corrente funny (if) para uso em um método de tratamento e prevenção de insuficiência cardíaca em felino
WO2013037650A1 (fr) 2011-09-15 2013-03-21 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
CZ308210B6 (cs) * 2011-11-02 2020-03-04 Veterinární A Farmaceutická Univerzita Brno Farmaceutická kompozice ve formě pelet majících velikost částic v rozmezí od 0,1 do 10 mm pro perorální podání vodním živočichům a způsob její výroby
EP3034071B1 (fr) 2011-12-21 2017-12-06 Elanco Tiergesundheit AG Nouvelle combinaison
EP3167876B1 (fr) * 2012-03-15 2021-09-08 Boehringer Ingelheim Vetmedica GmbH Formulation de comprimé pharmaceutique pour le secteur vétérinaire, son procédé de production et d'utilisation
WO2013135853A1 (fr) * 2012-03-15 2013-09-19 Boehringer Ingelheim Vetmedica Gmbh Produit pharmaceutique sous emballage pour le secteur médical vétérinaire
DK179072B1 (da) * 2012-05-08 2017-10-09 Novartis Tiergesundheit Ag Ny Behandling
FR2991179B1 (fr) * 2012-06-01 2016-11-11 Ceva Sante Animale Compositions veterinaires orales appetentes
CA2883139C (fr) 2012-08-31 2021-08-10 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
WO2014053555A1 (fr) 2012-10-04 2014-04-10 Novartis Ag Système de médicament vétérinaire
FR3002735B1 (fr) 2013-03-04 2015-07-03 Virbac Composition orale nutritionnelle et medicamenteuse a usage veterinaire
FR3002736B1 (fr) 2013-03-04 2015-06-26 Virbac Composition orale nutritionnelle et medicamenteuse a usage veterinaire
CN113181110A (zh) 2013-07-19 2021-07-30 勃林格殷格翰动物保健有限公司 含有防腐的醚化的环糊精衍生物的液体水性药物组合物
BR112016011111B1 (pt) 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
KR101687973B1 (ko) * 2015-12-08 2016-12-21 주식회사 씨티씨바이오 마이크로필름 코팅을 이용한 동물 사료용 프리믹스 제조방법
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN105963270B (zh) * 2016-06-30 2019-01-15 齐鲁动物保健品有限公司 一种盐酸贝那普利软咀嚼片及其制备方法
CN109673848A (zh) * 2018-12-29 2019-04-26 广州智特奇生物科技股份有限公司 一种肠溶包被材料、肠道缓释单宁酸及其制备方法
JP7534139B2 (ja) 2020-07-03 2024-08-14 獣医医療開発株式会社 動物用医薬製剤
CN112220769A (zh) * 2020-08-13 2021-01-15 浙江海正动物保健品有限公司 一种米尔贝肟吡喹酮风味片及其制备方法
JP2023540312A (ja) 2020-09-04 2023-09-22 エランコ・ユーエス・インコーポレイテッド 口当たりの良い製剤
SI4037666T1 (sl) 2020-12-08 2024-09-30 Ruminant Biotech Corp Limited Izboljšave naprav in postopkov za dostavo snovi živalim
CN113768038A (zh) * 2021-09-14 2021-12-10 江苏省协同医药生物工程有限责任公司 一种精准定量实验动物功能性饲料及制备方法与设备
JP7109827B1 (ja) * 2021-11-16 2022-08-01 株式会社ハニック・ホワイトラボ 抗ウイルス剤

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3231466A (en) * 1962-10-26 1966-01-25 Walter H Hoffman Composition and method for treating animals and poultry
US3824233A (en) * 1972-07-06 1974-07-16 Lilly Co Eli Anthelmintic phenylhydrazones
US3937825A (en) * 1973-09-21 1976-02-10 American Cyanamid Company Anthelmintic composition and method of use
US4708867A (en) * 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
JPS63188621A (ja) * 1987-01-30 1988-08-04 Taisho Pharmaceut Co Ltd 矯味経口製剤
EP0524180B1 (fr) * 1990-04-11 1995-04-26 The Upjohn Company Masquage du gout de l'ibuprofene
ATE217789T1 (de) * 1992-06-04 2002-06-15 Smithkline Beecham Corp Angenehm schmeckende pharmazeutische zusammensetzungen
SE9301489D0 (sv) * 1993-04-30 1993-04-30 Ab Astra Veterinary composition
ES2167436T3 (es) * 1994-05-20 2002-05-16 Janssen Pharmaceutica Nv Tabletas de flubendazol masticables para animales de compañia.
SE9402422D0 (sv) 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
SE9600071D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
CA2269078C (fr) * 1996-10-16 2012-01-24 Shaman Pharmaceuticals, Inc. Formulations enterales de compositions polymeres pro-anthocyanidiques a proprietes anti-diarrheiques
TWI257311B (en) * 1998-07-28 2006-07-01 Takeda Chemical Industries Ltd Rapidly disintegrable solid preparation
US5997905A (en) * 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB2356346A (en) * 1999-11-19 2001-05-23 Mars Uk Ltd Food product for oral delivery of a pharmaceutical agent to a non-human animal comprising encapsulated particles of said agent distributed within the product
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
KR20030088453A (ko) 2001-03-09 2003-11-19 소시에떼 데 프로듀이 네슬레 소시에떼아노님 연령 관련 생리학적 부전 개선 및 수명 연장을 위한 조성물
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals

Also Published As

Publication number Publication date
CA2478811A1 (fr) 2003-09-18
AR038899A1 (es) 2005-02-02
SI1490037T1 (sl) 2008-08-31
RU2004130433A (ru) 2005-08-10
CO5400144A1 (es) 2004-05-31
CN1652754B (zh) 2013-05-22
CA2478811C (fr) 2010-12-14
JP2005526756A (ja) 2005-09-08
RU2318498C2 (ru) 2008-03-10
TW200304774A (en) 2003-10-16
DE60319969D1 (de) 2008-05-08
PT1490037E (pt) 2008-05-05
CN1652754A (zh) 2005-08-10
BR0308378A (pt) 2005-01-11
US20100074952A1 (en) 2010-03-25
AU2003218722B2 (en) 2006-08-31
WO2003075895A1 (fr) 2003-09-18
US8617587B2 (en) 2013-12-31
US20050169971A1 (en) 2005-08-04
AU2003218722A1 (en) 2003-09-22
KR20040101302A (ko) 2004-12-02
MXPA04008845A (es) 2004-11-26
DE60319969T2 (de) 2009-04-30
NZ535167A (en) 2006-08-31
ZA200407010B (en) 2006-06-28
ES2301784T3 (es) 2008-07-01
TWI309557B (en) 2009-05-11
EP1803448A3 (fr) 2007-09-12
EP1803448A2 (fr) 2007-07-04
JP4663985B2 (ja) 2011-04-06
EP1490037B1 (fr) 2008-03-26
EP1490037A1 (fr) 2004-12-29
ATE390129T1 (de) 2008-04-15
BR0308378B1 (pt) 2013-12-24

Similar Documents

Publication Publication Date Title
DK1490037T3 (da) Smagsmaskeret faste sammensætninger af veterinærmedicin
DK1297825T3 (da) Faste orale dosisformer af simethicon
DK1545467T3 (da) Faste farmaceutiske formuleringer omfattende telmisartan
DK1763673T3 (da) Anvendelser af gelformuleringer
IS7714A (is) Lyfjasamsetningar úr módafíníl
DK2172205T3 (da) Farmaceutisk formulering bestående af lanthan-forbindelser
DE60318890D1 (de) Mandelsäure derivate
DK3395339T3 (da) Hurtigt opløsende formulering af cinacalcet-hcl
DK1549153T3 (da) Tyggegummi med forbedret frigivelse af tyggegummiingredienser
PT1501534E (pt) Formulacoes farmaceuticas
DK1542660T3 (da) Administration af langvarig frigørelse af amfetaminsalte
MA28490B1 (fr) Formulations galeniques de composes organiques
DK1673104T4 (da) Fremføring af terapeutiske forbindelser til hjernen og andre væv
CY2018005I2 (el) Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
DK1599186T3 (da) System til administration af transmukalt lægemiddel
DK1425019T3 (da) Farmaceutisk sammensætning omfattende et androgen
NO20040125L (no) Enterale formuleringer
MX266708B (es) Formulaciones de microparticulas de pantoprazol.
DK1601359T3 (da) Væskeformige, farmaceutiske formuleringer af palonosetron
IS2707B (is) Nýjar lyfjasamsetningar úr módafíníli
DK1622612T3 (da) Farmaceutisk formulering af natriumsaltet af telmitarsan
IS7051A (is) Lyfjasamsetningar
DK1463551T3 (da) Veterinærmedicinsk spröjte
NO20044722L (no) Hoy dose av ibandronat formulering
NO20043937L (no) Anvendelse av vitamin D sammensetninger